Log In / Sign Up

SB 675

  • Pennsylvania Senate Bill
  • 2019-2020 Regular Session
  • Introduced in Senate
  • Passed Senate Jun 17, 2019
  • House
  • Governor

An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.

View Latest Bill Text
Sign In to Follow

Abstract

Bill Sponsors (7)

Brooks

     
Primary

Patrick M. Browne

  • Republican
Cosponsor

Scott Hutchinson

  • Republican
  • Senator
  • District 21
Cosponsor

Pat Stefano

  • Republican
  • Senator
  • District 32
Cosponsor

K. Ward

     
Cosponsor

Thomas H. Killion

  • Republican
Cosponsor

Mike Folmer

  • Republican
Cosponsor

Votes

Jun 17, 2019

FINAL PASSAGE

Pass

Senate

Jun 10, 2019

Committee vote (APPROPRIATIONS): Re-Reported as Committed

Pass

Senate

Jun 04, 2019

Committee vote (HEALTH AND HUMAN SERVICES): Reported as Committed

Pass

Senate

Actions

Jun 18, 2019

House

Referred to HUMAN SERVICES

Jun 17, 2019

Senate

Third consideration and final passage

Jun 10, 2019

Senate

Re-reported as committed

Jun 05, 2019

Senate

Re-referred to APPROPRIATIONS

Senate

Second consideration

Jun 04, 2019

Senate

First consideration

Senate

Reported as committed

May 28, 2019

Senate

PN 0820 Referred to HEALTH AND HUMAN SERVICES

Bill Text

Bill Text Versions Format
Printer's No. 0820 HTML PDF MSWORD

Related Documents

Document Format
Senate Fiscal Note PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Pennsylvania General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.